These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 24755339

  • 1. The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied.
    Schilder L, Nurmohamed SA, ter Wee PM, Paauw NJ, Girbes AR, Beishuizen A, Beelen RH, Groeneveld AB.
    Crit Care; 2014 Apr 22; 18(2):R78. PubMed ID: 24755339
    [Abstract] [Full Text] [Related]

  • 2. [The effect of continuous veno venous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in critically ill patients with acute kidney injury].
    Wang H, Cui N, Zhou YK, Cheng W, Li L, Long Y, Liu DW.
    Zhonghua Nei Ke Za Zhi; 2018 Apr 01; 57(4):285-289. PubMed ID: 29614588
    [Abstract] [Full Text] [Related]

  • 3. Effect of anticoagulation regimens on handling of interleukin-6 and -8 during continuous venovenous hemofiltration in critically ill patients with acute kidney injury.
    Schilder L, Nurmohamed SA, ter Wee PM, Girbes AR, Beishuizen A, Paauw NJ, Beelen RH, Groeneveld AB.
    Cytokine; 2012 Dec 01; 60(3):601-7. PubMed ID: 23006672
    [Abstract] [Full Text] [Related]

  • 4. The effect of continuous venovenous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in patients with septic acute kidney injury.
    Dai X, Li T, Zeng Z, Fu C, Wang S, Cai Y, Chen Z.
    BMC Nephrol; 2016 Oct 19; 17(1):154. PubMed ID: 27760529
    [Abstract] [Full Text] [Related]

  • 5. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury.
    Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Fliser D, Faulhaber-Walter R, Kielstein JT.
    Crit Care; 2010 Oct 19; 14(1):R9. PubMed ID: 20122150
    [Abstract] [Full Text] [Related]

  • 6. Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities.
    Schilder L, Nurmohamed SA, ter Wee PM, Paauw NJ, Girbes AR, Beishuizen A, Beelen RH, Groeneveld AB.
    BMC Nephrol; 2015 Oct 30; 16():178. PubMed ID: 26519056
    [Abstract] [Full Text] [Related]

  • 7. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L, Nurmohamed SA, Bosch FH, Purmer IM, den Boer SS, Kleppe CG, Vervloet MG, Beishuizen A, Girbes AR, Ter Wee PM, Groeneveld AB, CASH study group.
    Crit Care; 2014 Aug 16; 18(4):472. PubMed ID: 25128022
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
    Ricci Z, Morelli S, Favia I, Garisto C, Brancaccio G, Picardo S.
    Pediatr Crit Care Med; 2012 Jan 16; 13(1):e51-4. PubMed ID: 21057360
    [Abstract] [Full Text] [Related]

  • 9. Removal of neutrophil gelatinase-associated lipocalin by extracorporeal therapies.
    Bobek I, Gong D, De Cal M, Cruz D, Chionh CY, Haapio M, Soni SS, Nalesso F, Lentini P, Garzotto F, Corradi V, Ronco C.
    Hemodial Int; 2010 Jul 16; 14(3):302-7. PubMed ID: 20500227
    [Abstract] [Full Text] [Related]

  • 10. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P, Kijkriengkraikul N, Leelahavanichkul A, Srisawat N, Praditpornsilpa K, Eiam-Ong S.
    Ther Apher Dial; 2011 Dec 16; 15(6):556-64. PubMed ID: 22107692
    [Abstract] [Full Text] [Related]

  • 11. Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients.
    Schilder L, Nurmohamed SA, ter Wee PM, Paauw NJ, Girbes AR, Beishuizen A, Beelen RH, Groeneveld AB.
    BMC Nephrol; 2014 Jan 17; 15():19. PubMed ID: 24438360
    [Abstract] [Full Text] [Related]

  • 12. Plasma neutrophil gelatinase-associated lipocalin as early biomarker for acute kidney injury in burn patients.
    Hong DY, Lee JH, Park SO, Baek KJ, Lee KR.
    J Burn Care Res; 2013 Jan 17; 34(6):e326-32. PubMed ID: 23511281
    [Abstract] [Full Text] [Related]

  • 13. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness.
    Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, D'amico G, Goldsmith D, Devarajan P, Bellomo R.
    Intensive Care Med; 2010 Mar 17; 36(3):452-61. PubMed ID: 19956924
    [Abstract] [Full Text] [Related]

  • 14. Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis.
    Kim H, Hur M, Cruz DN, Moon HW, Yun YM.
    Clin Biochem; 2013 Oct 17; 46(15):1414-8. PubMed ID: 23747960
    [Abstract] [Full Text] [Related]

  • 15. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study.
    Dent CL, Ma Q, Dastrala S, Bennett M, Mitsnefes MM, Barasch J, Devarajan P.
    Crit Care; 2007 Oct 17; 11(6):R127. PubMed ID: 18070344
    [Abstract] [Full Text] [Related]

  • 16. Plasma neutrophil gelatinase-associated lipocalin as a predictive biomarker for the detection of acute kidney injury in adult poisoning.
    Ahn JY, Lee MJ, Seo JS, Choi D, Park JB.
    Clin Toxicol (Phila); 2016 Oct 17; 54(2):127-33. PubMed ID: 26683351
    [Abstract] [Full Text] [Related]

  • 17. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury.
    Liu DL, Huang LF, Ma WL, Ding Q, Han Y, Zheng Y, Li WX.
    Chin Med J (Engl); 2016 Jul 20; 129(14):1682-7. PubMed ID: 27411455
    [Abstract] [Full Text] [Related]

  • 18. Coagulation, Fibrinolysis and Inhibitors in Failing Filters during Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: Effect of Anticoagulation Modalities.
    Schilder L, Nurmohamed SA, ter Wee PM, Paauw NJ, Girbes AR, Beishuizen A, Beelen RH, Groeneveld AB.
    Blood Purif; 2015 Jul 20; 39(4):297-305. PubMed ID: 25966765
    [Abstract] [Full Text] [Related]

  • 19. Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe.
    Honore PM, Jacobs R, Hendrickx I, De Waele E, Van Gorp V, Spapen HD.
    Crit Care; 2015 Nov 17; 19():392. PubMed ID: 26573621
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.